Indoco Remedies Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1947

Chairman: Suresh G Kare

Managing Director: Aditi Panandikar

Group: --

Listing: NSE: INDOCO, BSE: 532612

Headquarters: Mumbai, Maharashtra

Website: www.indoco.com

Key Facts

Market cap: R 2,067.85 Cr

Revenue (TTM): R 1,086.00 Cr

Earnings (TTM): R 30.48 Cr

Cash: R 36.26 Cr

Total Debt: R 296.31 Cr

Promoters' ownership: 58.69%

Liquidity: High

52 Week range: R 132.45 - 285.00

Face value: R2.00

Shares outstanding: 9,21,50,355

10 Years Aggregate:

CFO: 886.95 Cr
EBITDA: 1,112.91 Cr
Net Profit: 520.42 Cr

Stock Performance

Trailing
Annual

Time Period	Indoco Remedies	S&P BSE Healthcare	S&P BSE Small Cap
YTD	17.54	20.33	-13.46
1 month	-2.41	6.87	11.32
3 months	-8.86	14.23	-12.77
1 Year	25.28	21.43	-20.39
3 Years	4.60	5.22	-8.36
5 Years	-9.16	0.31	1.78
10 Years	15.22	11.35	3.21

As on 05-Jun-2020

Year	Indoco Remedies	S&P BSE Small Cap	S&P BSE Healthcare
2019	-12.11	-6.85	-3.55
2018	-22.68	-23.41	-5.89
2017	7.62	59.64	0.49
2016	-18.71	1.77	-12.88
2015	3.66	6.76	15.06
2014	131.35	69.24	47.43
2013	116.83	-11.23	22.55

Annual Report (FY18)

Review & Analysis

Scaling up R&D efforts to expand possibilities
Jugal Harpalani . 01-Jul-2019

News & Announcements